Wikidata

(Q61970111)

English

An Observational Safety Study in Zelboraf (Vemurafenib)-Treated Patients With BRAF-V600 Mutation-Positive Unresectable or Metastatic Melanoma (ZeSS)

clinical trial

In more languages

Statements

title
ZeSS: A Prospective Observational Safety Study of Patients With BRAF-V600 Mutation-positive Unresectable or Metastatic Melanoma Treated With Vemurafenib (Zelboraf®) (English)
0 references
sponsor
Hoffmann-La Roche
0 references
country
Austria
0 references
Belgium
0 references
Germany
0 references
Republic of Ireland
0 references
Italy
0 references
Netherlands
0 references
Poland
0 references
Sweden
0 references
United Kingdom
0 references
start time
23 March 2013
0 references
end time
26 July 2016
0 references
number of participants
339
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61970111&oldid=2149158178"